Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.
(Japan AND ("Novel Coronavirus" OR COVID-19 OR SARS-CoV-2 OR 2019-nCoV))
358 results
  • A case of SARS-CoV-2 infection in an untreated HIV patient in Tokyo, Japan. [Letter]
    J Med Virol. 2020 Jun 03 [Online ahead of print]Nakamoto T, Kutsuna S, … Ohmagari N
  • We report a 28-year-old male co-infected with SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2; COVID-19) and human immunodeficiency virus (HIV). His clinical course of the COVID-19 pneumonia improved smoothly in 9 days; however, his immune status from HIV infection was not well-controlled due to a lack of antiretroviral therapy (ART). The HIV-1 viral load decreased during the acute ph…
  • Screening for consequences of trauma - an update on the global collaboration on traumatic stress. [Journal Article]
    Eur J Psychotraumatol. 2020; 11(1):1752504.Olff M, Bakker A, … Schnyder U
  • This letter provides an update on the activities of "The Global Collaboration on Traumatic Stress" (GC-TS) as first described by Schnyder et al. in 2017. It presents in further detail the projects of the first theme, in particular the development of and initial data on the Global Psychotrauma Screen (GPS), a brief instrument designed to screen for the wide range of potential outcomes of trauma. E…
  • Forecast Possible Risk for COVID-19 Epidemic Dissemination Under Current Control Strategies in Japan. [Journal Article]
    Int J Environ Res Public Health. 2020 May 29; 17(11)Chen Z, Yang J, Dai B
  • COVID-19 has globally spread to over 4 million people and the epidemic situation in Japan is very serious. The purpose of this research was to assess the risk of COVID-19 epidemic dissemination in Japan by estimating the current state of epidemic dissemination and providing some epidemic prevention and control recommendations. Firstly, the period from 6 January to 31 March 2020 was divided into f…
  • The impact of the COVID-19 pandemic on eating disorder risk and symptoms. [Journal Article]
    Int J Eat Disord. 2020 Jun 01 [Online ahead of print]Rodgers RF, Lombardo C, … Guillaume S
  • The current COVID-19 pandemic has created a global context likely to increase eating disorder (ED) risk and symptoms, decrease factors that protect against EDs, and exacerbate barriers to care. Three pathways exist by which this pandemic may exacerbate ED risk. One, the disruptions to daily routines and constraints to outdoor activities may increase weight and shape concerns, and negatively impac…
  • Pharmacokinetics of Favipiravir in Critically Ill Patients with COVID-19. [Journal Article]
    Clin Transl Sci. 2020 May 31 [Online ahead of print]Irie K, Nakagawa A, … Hashida T
  • Since December 2019, a novel coronavirus (SARS-CoV-2) infection has been rapidly spreading worldwide and causing the respiratory illness, coronavirus disease 2019 (COVID-19). The anti-retroviral drug favipiravir (FPV) has been experimentally used for COVID-19 treatment since March 2020 in Japan. However, the pharmacokinetics of FPV in critically ill patients is unknown. We measured the serum conc…
  • Neuroleptic malignant syndrome in patients with COVID-19. [Case Reports]
    Am J Emerg Med. 2020 May 22 [Online ahead of print]Soh M, Hifumi T, … Ishimatsu S
  • We report the first two cases of Coronavirus Disease 2019 (COVID-19) who were receiving intensive care including favipiravir, and were clinically diagnosed with neuroleptic malignant syndrome (NMS) to focus attention on NMS in COVID-19 management. Case 1: A 46-year-old-man with acute respiratory distress syndrome (ARDS) caused by COVID-19 infection was being administered favipiravir. Fentanyl, pr…
  • Imported and locally transmitted mild SARS-CoV-2 pneumonia cases in Japan. [Case Reports]
    J Infect Chemother. 2020 May 21 [Online ahead of print]Tochitani K, Iwamoto N, … Shimizu T
  • Here, we describe two mild SARS-CoV-2 pneumonia cases. One was imported from Wuhan, and the other was locally transmitted in Japan without recent travel to China. In both cases, lower respiratory tract symptoms were observed first, and high fever progressed in about one week. The laboratory findings revealed normal WBC and CRP despite apparent lung infiltrations, and typical observations on CT im…
  • Transmission routes of SARS-CoV-2 and protective measures in dental clinics during the COVID-19 pandemic. [Review]
    Am J Dent. 2020 Jun; 33(3):129-134.Pan Y, Liu H, … Lu S
  • CONCLUSIONS: This paper, based on proven effective experience, relevant guidelines, and research, not only presents the fundamental knowledge about the name, etiologic characteristics, epidemiologic characteristics and clinical manifestations of COVID-19, transmission routes and risk points of SARS-CoV-2 in dental clinics but also provides recommended protective measures for dental professionals to interdict the transmission of SARS-CoV-2 in dental clinics.
New Search Next